Roslyn Ristuccia (BSc; MSc(ClinEpi); DipCSc) is the Clinical Research Unit Manager at Cancer Care Center, St George Hospital, NSW, Australia. With a background in laboratory science in biotechnology and quality management, she made a switch to clinical research and now has over 20 years of management expertise in this area. She was a senior lecturer at University of Sydney in post graduate studies in Clinical Data Management. She has a passion for databases, quality standards, and for collaboration. It was this drive for collaboration that led her to chair a state-wide Trial Managers Network, where the idea for ClinTrial Refer was able to be realised. With co-inventor, Dr Judith Trotman, the combination of trial units and doctors precipitated change for the better for patients. ClinTrial Refer has enabled doctors to have current and comprehensive information about recruiting trials in their pocket- to be used at point of consultation. The data comes from the trial units. Patients are offered all options available to them. Trial units recruit more quickly and reach targets, and patients benefit from new emerging therapies. Doctors are able to change the way that they refer to trials because they have the trial knowledge and contact details available quickly. Herox has enabled us to reach out and show our solution – ClinTrial Refer for increasing recruitment- to a much wider audience. The solution is evidence-based, and easily replicated, because it solves one of the major barriers to timely clinical research recruitment. The Herox Community is basically one of collaboration, and so a community that we want to collaborate with. Judith Trotman is a Senior Staff Specialist Haematologist, and the Director of the Clinical Research Unit at Concord Hospital, Sydney where she has built a broad portfolio of trials across the spectrum of haematologic malignancies, accessing emerging new therapies for patients from across New South Wales, Australia. She has particular expertise in the management of lymphoid malignancies. Committed to local and international collaboration in investigator initiated research she is a member of the Australasian Leukaemia Lymphoma Group (ALLG) Scientific Advisory Committee and the ALLG Principal Investigator for five lymphoma studies: REMARC, RATHL, IRiC, RePLY, and a lymphoma PET project where she leads European researchers in demonstrating the predictive power of PET imaging in follicular lymphoma (Journal of Clinical Oncology and Lancet Haematology). The RATHL study was recently published in NEJM June 2016. She is an author of the 2014 international guidelines in staging and response assessment of Lymphoma (Journal of Clinical Oncology). She and Roslyn Ristuccia were awarded the 2015 Premier’s Award for Outstanding Cancer Research - Innovation in Clinical Trials, as co-inventor of ClinTrial Refer – an innovative cross-referral smart-phone App that is facilitating patient access to clinical trials across Australia. Visit www.clintrial.org.au for more information.